Document Detail

Is there life after Buckley's Formocresol? Part I -- a narrative review of alternative interventions and materials.
MedLine Citation:
PMID:  16430526     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: (1) To present a narrative review of the currently available alternative interventions and materials to formocresol pulpotomy for the management of extensive caries in the primary molar, and (2) to produce a clinical protocol for pulp therapy techniques in the extensively carious primary molar. INTRODUCTION: The International Agency for Research on Cancer has recently classified formaldehyde as carcinogenic to human beings. Since Buckley's Formocresol contains 19% formaldehyde in its full strength and, therefore, 1% in a 20% dilution, a safer alternative should be identified. METHODS: A narrative review of the published literature for primary molar pulp therapy techniques was undertaken following an extensive and appropriate literature search. A specialist group of paediatric dentists was formed to arrive at a consensus and establish an evidence-based protocol for the management of extensively carious primary molar teeth. Part I of this paper explores the currently available alternative interventions and materials to formocresol in the form of a narrative review. The second part of the paper will present the formation of a specialist group to arrive at a consensus and establish an evidence-based protocol for the management of the extensively carious primary molar. CONCLUSIONS: After consideration of a review of extensively searched literature, a protocol and key points document have been developed to assist clinicians in their treatment planning. Further long-term studies with the highest level of evidence (i.e. randomized controlled trials) are required to enable us to identify acceptable alternatives which can replace formocresol.
V Srinivasan; C L Patchett; P J Waterhouse
Related Documents :
11019556 - Chondrosarcoma of the anterior mandible. a case report.
8839336 - The role of the occlusal wafer in orthognathic surgery; a comparison of thick and thin ...
16158796 - Forced eruption: review and case reports.
15853276 - Permanent double teeth and hypodontia in a pair of monozygotic twins: case report.
11528636 - Pylephlebitis, portal-mesenteric thrombosis, and multiple liver abscesses owing to perf...
2073036 - Fournier's gangrene. report of three cases and review of the literature.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  International journal of paediatric dentistry / the British Paedodontic Society [and] the International Association of Dentistry for Children     Volume:  16     ISSN:  0960-7439     ISO Abbreviation:  Int J Paediatr Dent     Publication Date:  2006 Mar 
Date Detail:
Created Date:  2006-01-24     Completed Date:  2006-04-04     Revised Date:  2010-10-22    
Medline Journal Info:
Nlm Unique ID:  9107511     Medline TA:  Int J Paediatr Dent     Country:  England    
Other Details:
Languages:  eng     Pagination:  117-27     Citation Subset:  D    
Department of Child Dental Health, Newcastle Dental Hospital, Newcastle upon Tyne, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aluminum Compounds / therapeutic use
Bone Morphogenetic Proteins / therapeutic use
Calcium Compounds / therapeutic use
Calcium Hydroxide / therapeutic use
Camphor / therapeutic use
Collagen / therapeutic use
Demeclocycline / therapeutic use
Dental Pulp Capping / methods
Dental Pulp Devitalization / methods
Dental Pulp Exposure / therapy*
Drug Combinations
Ferric Compounds / therapeutic use
Glutaral / therapeutic use
Hydrocarbons, Iodinated / therapeutic use
Laser Therapy
Oxides / therapeutic use
Pulpectomy / methods
Pulpotomy / methods*
Root Canal Filling Materials / therapeutic use
Silicates / therapeutic use
Silicones / therapeutic use
Tooth Remineralization / methods
Triamcinolone Acetonide / therapeutic use
Zinc Oxide-Eugenol Cement / therapeutic use
Reg. No./Substance:
0/Aluminum Compounds; 0/Bone Morphogenetic Proteins; 0/Calcium Compounds; 0/Drug Combinations; 0/Ferric Compounds; 0/Formocresols; 0/Hydrocarbons, Iodinated; 0/Oxides; 0/Root Canal Filling Materials; 0/Silicates; 0/Silicones; 0/Zinc Oxide-Eugenol Cement; 0/calcium hydroxide, iodoform, silicone oil drug combination; 0/mineral trioxide aggregate; 10028-22-5/ferric sulfate; 111-30-8/Glutaral; 11132-72-2/Kri paste; 127-33-3/Demeclocycline; 1305-62-0/Calcium Hydroxide; 37203-87-5/formocresol; 76-22-2/Camphor; 76-25-5/Triamcinolone Acetonide; 8059-68-5/Ledermix; 9007-34-5/Collagen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fluoride content of bottled waters available in Northern Greece.
Next Document:  Solitary median maxillary central incisor and normal stature: a report of three cases.